Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 3/8/20121 min de lectura
Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT); Public Workshop
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research is announcing a 4-day public workshop entitled "Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT)." The purpose of this workshop is to provide a forum to consider issues related to endpoints that can support drug development in the following disease areas: Eosinophilic esophagitis, pediatric and adult inflammatory bowel disease, and parenteral nutrition-associated liver disease.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →